Stay updated on Nivolumab in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The clinical trial page now displays the study record for neoadjuvant nivolumab-based treatment of resectable non-small-cell lung cancer, including its design, eligibility criteria, locations, and outcomes.
    Difference
    73%
    Check dated 2026-11-08T15:22:47.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:18:38.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner was added above the page announcing NIH website transition updates and noting that both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.
    Difference
    1%
    Check dated 2026-10-25T16:20:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:07:31.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:13:46.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with a restricted view. Users can only see a generic header and a Home link, which means the trial information is not currently accessible.
    Difference
    20%
    Check dated 2026-09-20T22:30:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.